Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of August 2026

  1. Vor Biopharma Inc.

    World Rank (Aug-2026)
    7,864
    Market Cap (Aug-2026)
    1.363 Billion USD
    World Rank (Jan-05-2024)
    19,708
    Market Cap (Jan-05-2024)
    0.141 Billion USD
    World Rank (Jul-30-2023)
    18,336
    Market Cap (Jul-30-2023)
    0.189 Billion USD
    World Rank (Dec-25-2022)
    12,953
    Market Cap (Dec-25-2022)
    0.460 Billion USD
    World Rank (Jan-07-2022)
    14,870
    Market Cap (Jan-07-2022)
    0.40 Billion USD
    Annual Operating Income in USD
    -372 Million USD
    Annual Net Income in USD
    -696 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  2. Alpha Tau Medical Ltd.

    World Rank (Aug-2026)
    7,981
    Market Cap (Aug-2026)
    1.328 Billion USD
    World Rank (Jan-05-2024)
    17,815
    Market Cap (Jan-05-2024)
    0.202 Billion USD
    World Rank (Jul-30-2023)
    16,551
    Market Cap (Jul-30-2023)
    0.265 Billion USD
    World Rank (Dec-25-2022)
    17,769
    Market Cap (Dec-25-2022)
    0.210 Billion USD
    Headquarters Country
  3. Monte Rosa Therapeutics Inc.

    World Rank (Aug-2026)
    8,001
    Market Cap (Aug-2026)
    1.322 Billion USD
    World Rank (Jan-05-2024)
    15,682
    Market Cap (Jan-05-2024)
    0.304 Billion USD
    World Rank (Jul-30-2023)
    14,960
    Market Cap (Jul-30-2023)
    0.350 Billion USD
    World Rank (Dec-25-2022)
    14,146
    Market Cap (Dec-25-2022)
    0.384 Billion USD
    World Rank (Jan-07-2022)
    10,718
    Market Cap (Jan-07-2022)
    0.79 Billion USD
    Annual Revenue in USD
    124 Million USD
    Annual Operating Income in USD
    -54 Million USD
    Annual Net Income in USD
    -39 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  4. Schrodinger Inc.

    World Rank (Aug-2026)
    8,016
    Market Cap (Aug-2026)
    1.316 Billion USD
    World Rank (Jan-05-2024)
    5,184
    Market Cap (Jan-05-2024)
    2.332 Billion USD
    World Rank (Jul-30-2023)
    3,873
    Market Cap (Jul-30-2023)
    3.545 Billion USD
    World Rank (Dec-25-2022)
    7,039
    Market Cap (Dec-25-2022)
    1.344 Billion USD
    World Rank (Jan-07-2022)
    5,797
    Market Cap (Jan-07-2022)
    2.26 Billion USD
    Annual Revenue in USD
    256 Million USD
    Annual Operating Income in USD
    -167 Million USD
    Annual Net Income in USD
    -103 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Schrodinger is the scientific leader in developing state of the art chemical simulation software for use in pharmaceutical, Biotechnology and Materials Research company. The headquarters is in USA.

    Facts About Company

    Schrodinger Annual Total Revenue for year ending Dec-2022 was 180 million USD and and Net loss for year ending Dec-2022 was -149 million USD.

    Schrodinger Annual Total Revenue for year ending Dec-2021 was 137 million USD and and Net loss for year ending Dec-2021 was -100 million USD.

    As on 2022, Schrodinger has 787 employees.

  5. Cullinan Oncology Inc.

    World Rank (Aug-2026)
    8,035
    Market Cap (Aug-2026)
    1.309 Billion USD
    World Rank (Jan-05-2024)
    13,291
    Market Cap (Jan-05-2024)
    0.447 Billion USD
    World Rank (Jul-30-2023)
    14,109
    Market Cap (Jul-30-2023)
    0.401 Billion USD
    World Rank (Dec-25-2022)
    12,838
    Market Cap (Dec-25-2022)
    0.469 Billion USD
    World Rank (Jan-07-2022)
    11,894
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Annual Operating Income in USD
    -242 Million USD
    Annual Net Income in USD
    -220 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  6. Inhibrx Inc.

    World Rank (Aug-2026)
    8,088
    Market Cap (Aug-2026)
    1.296 Billion USD
    World Rank (Jan-05-2024)
    6,046
    Market Cap (Jan-05-2024)
    1.809 Billion USD
    World Rank (Jul-30-2023)
    7,998
    World Rank (Dec-25-2022)
    7,998
    Market Cap (Dec-25-2022)
    1.081 Billion USD
    World Rank (Jan-07-2022)
    8,138
    Market Cap (Jan-07-2022)
    1.29 Billion USD
    Annual Revenue in USD
    1 Million USD
    Annual Operating Income in USD
    -135 Million USD
    Annual Net Income in USD
    -140 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Inhibrx is a Clinical Stage Biotechnology company developed a diverse pipeline of therapeutic candidates specifically designed to leverage the power of core sdAb (single-domain antibody) platform and protein engineering expertise. The company annual revenue is 34.1 million USD and 80 employees as on 2020. The headquarters is in USA.
  7. Corvus Pharmaceuticals

    World Rank (Aug-2026)
    8,245
    Market Cap (Aug-2026)
    1.253 Billion USD
    World Rank (Jan-05-2024)
    21,283
    Market Cap (Jan-05-2024)
    0.103 Billion USD
    World Rank (Jul-30-2023)
    21,344
    Market Cap (Jul-30-2023)
    0.107 Billion USD
    World Rank (Dec-25-2022)
    26,383
    Market Cap (Dec-25-2022)
    0.039 Billion USD
    World Rank (Jan-07-2022)
    23,020
    Market Cap (Jan-07-2022)
    0.10 Billion USD
    Annual Operating Income in USD
    -43 Million USD
    Annual Net Income in USD
    -15 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  8. Omeros Corporation

    World Rank (Aug-2026)
    8,269
    Market Cap (Aug-2026)
    1.244 Billion USD
    World Rank (Jan-05-2024)
    18,164
    Market Cap (Jan-05-2024)
    0.190 Billion USD
    World Rank (Jul-30-2023)
    16,148
    Market Cap (Jul-30-2023)
    0.285 Billion USD
    World Rank (Dec-25-2022)
    19,264
    Market Cap (Dec-25-2022)
    0.159 Billion USD
    World Rank (Jan-07-2022)
    15,000
    Market Cap (Jan-07-2022)
    0.39 Billion USD
    Annual Operating Income in USD
    -123 Million USD
    Annual Net Income in USD
    -3 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Omeros is a Pharmaceutical Industry through novel discovery, strategic translational research and vigorous clinical programs. The company annual revenue is 13.5 million USD, total assets is 136.9 million USD and 265 employees as on 2020. The headquarters is in USA.
  9. MannKind Corporation

    World Rank (Aug-2026)
    8,298
    Market Cap (Aug-2026)
    1.238 Billion USD
    World Rank (Jan-05-2024)
    8,442
    Market Cap (Jan-05-2024)
    1.030 Billion USD
    World Rank (Jul-30-2023)
    7,743
    Market Cap (Jul-30-2023)
    1.224 Billion USD
    World Rank (Dec-25-2022)
    7,058
    Market Cap (Dec-25-2022)
    1.340 Billion USD
    World Rank (Jan-07-2022)
    9,303
    Market Cap (Jan-07-2022)
    1.02 Billion USD
    Annual Revenue in USD
    349 Million USD
    Annual Operating Income in USD
    39 Million USD
    Annual Net Income in USD
    6 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Mankind Corporation is a biopharmaceutical company with headquarters is in California, USA. It develops cutting-edge therapeutic products and technologies that help people take control of their health.
  10. Savara

    World Rank (Aug-2026)
    8,806
    Market Cap (Aug-2026)
    1.105 Billion USD
    World Rank (Jan-05-2024)
    11,588
    Market Cap (Jan-05-2024)
    0.591 Billion USD
    World Rank (Jul-30-2023)
    13,226
    Market Cap (Jul-30-2023)
    0.464 Billion USD
    World Rank (Dec-25-2022)
    18,880
    Market Cap (Dec-25-2022)
    0.171 Billion USD
    World Rank (Jan-07-2022)
    20,538
    Market Cap (Jan-07-2022)
    0.15 Billion USD
    Annual Operating Income in USD
    -124 Million USD
    Annual Net Income in USD
    -119 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country

Share

Ads